WHO experts issue recommendations on Moderna's coronavirus vaccine

The guidance on Moderna came several weeks after issuing their recommendations on the rival Pfizer vaccine

moderna, covid, vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
WHO director of immunisation Kate O'Brien said that clinical trials of the Moderna vaccine were needed on pregnant women
Reuters
2 min read Last Updated : Jan 26 2021 | 8:00 PM IST
The World Health Organization (WHO) issued recommendations on Tuesday on the use of the Moderna Covid-19 vaccine and said it was working with the company to accelerate its approval of the shot for WHO emergency use listing.
 
The WHO's Strategic Advisory Group of Experts on Immunization, known as SAGE, said that the vaccine should be given in two doses at an interval of 28 days, which could be extended under exceptional circumstances to 42 days.
 
The guidance on Moderna came several weeks after issuing their recommendations on the rival Pfizer vaccine.
 
"The main recommendation for the use of this (Moderna) vaccine is that based on the current elements we recommend it should be given in doses of 100 micrograms or 0.5 ml with an interval of 28 days," Alejandro Cravioto, panel chair, told a news briefing.
"This interval might be moved to 42 days but the evidence we have does not go beyond that time," he said.

After reviewing data the independent experts said it did not recommend the Moderna vaccine be used on pregnant women unless they are health workers exposed to the virus or have medical conditions putting them at high risk.
 
WHO director of immunisation Kate O'Brien said that clinical trials of the Moderna vaccine were needed on pregnant women.
 
"There is no reason to think there could be a problem in pregnancy, we are just acknowledging the data is not there at the moment," she said.
 
The WHO was liaising with Moderna on data it submitted as part of its application for WHO emergency use listing and would make a decision soon, she said, adding: "We are doing everything with Moderna to accelerate that process." The Pfizer and Moderna vaccines, both using mRNA technology, are "very similar", except for Pfizer requiring an ultra cold chain which is difficult for some countries, O'Brien said.
 
"We do recommend that you use the same vaccine for your second dose that you received for your first dose," she said.
In general, the WHO did not recommend vaccination for international travelers.
 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :World Health OrganizationCoronavirus VaccinePfizer

Next Story